NCT02711137 2025-10-21Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesIncyte CorporationPhase 1/2 Terminated137 enrolled 31 charts
NCT05768932 2025-10-15BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid LeukemiaSillaJen, Inc.Phase 1 Recruiting260 enrolled
NCT05828459 2025-03-20First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid TumorsOnward TherapeuticsPhase 1 Recruiting150 enrolled